AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Discover why indices rise or fall, examining earnings, macro data, and policy factors that shape broad market direction.
21,369 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Meta unveils a sweeping 5-GW AI data center expansion in rural Louisiana, widening a rift over economic benefits and ...
What if one cryptocurrency could outgrow Bitcoin and Ethereum combined? This article dives into the drivers, risks, a...
The Los Angeles Police Department is reworking its agreement with Flock Safety to add tighter privacy safeguards, kee...
Thinking about should tesla stock before July 22 earnings? This guide breaks down potential catalysts, risk factors, ...
Interactive Brokers grew customer accounts by 34% in the last year, signaling strong momentum in a competitive discou...
A small AI-focused player claims it helps customers turn modest marketing spend into impressive gains. This piece bre...
China’s DeepSeek AI forecasts notable upside for XRP, PEPE, and Shiba Inu through 2026, highlighting potential cataly...
A value-factor ETF has surged past the S&P 500 through February 2026, signaling a shift toward fundamentals amid vola...
Winter demand and a growing data-center footprint push grid strain. The Trump administration accelerates a coal reviv...
Supermicro, a key Nvidia partner, has not named a permanent CFO more than a year after an EY-led review urged leaders...
Amazon is quietly expanding its in-house silicon beyond data center basics, pushing Graviton and Trainium into broade...